Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 8,177 | 9,361 | 9,050 | 11,281 | 9,446 |
| Operating Income | -8,177 | -9,361 | -9,050 | -11,281 | -9,446 |
| Other Income | 41 | 94 | 210 | 184 | 325 |
| Pre-tax Income | -8,136 | -9,267 | -8,840 | -11,097 | -9,121 |
| Net Income Continuous | -8,136 | -9,267 | -8,840 | -11,097 | -9,121 |
| Net Income | $-8,136 | $-9,267 | $-8,840 | $-11,097 | $-9,121 |
| EPS Basic Total Ops | -0.23 | -0.33 | -0.31 | -0.47 | -0.33 |
| EPS Basic Continuous Ops | -0.23 | -0.33 | -0.31 | -0.47 | -0.32 |
| EPS Diluted Total Ops | -0.23 | -0.33 | -0.31 | -0.47 | -0.33 |
| EPS Diluted Continuous Ops | -0.23 | -0.33 | -0.31 | -0.47 | -0.32 |
| EBITDA(a) | $-8,177 | $-9,361 | $-9,050 | $-11,281 | $-9,446 |